Sildenafil-induced spinal cord infarction: a case report

Acta Neurol Belg. 2024 Aug;124(4):1353-1356. doi: 10.1007/s13760-024-02573-2. Epub 2024 May 18.

Abstract

Spinal cord infarction is a rare condition, accounting for only a small percentage of strokes. It can be classified into cervical and thoracolumbar infarctions, with various factors contributing to its occurrence. Sildenafil, a phosphodiesterase type 5 inhibitor commonly used for erectile dysfunction, has been associated with cardiovascular side effects, including transient hypotension. In this case report, we present the unusual occurrence of spinal cord infarction in a 65-year-old man who had self-administered high doses of sildenafil without a doctor's prescription. The patient experienced severe radicular pain in the lumbar region and subsequent weakness in the lower limbs. Evaluation revealed an anterior spinal cord infarction in the thoracic region, confirmed by MRI imaging. After excluding other potential causes, it was concluded that the intake of sildenafil likely led to systemic hypotension, resulting in spinal cord infarction. This case highlights the importance of considering sildenafil as a possible contributor to spinal cord infarction, particularly when used at high doses. Further studies are needed to better understand the relationship between sildenafil and vascular complications, including spinal cord infarction.

Keywords: Infarction; Sildenafil; Spinal cord.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Humans
  • Infarction* / chemically induced
  • Infarction* / diagnostic imaging
  • Magnetic Resonance Imaging
  • Male
  • Phosphodiesterase 5 Inhibitors* / adverse effects
  • Sildenafil Citrate* / adverse effects
  • Sildenafil Citrate* / therapeutic use
  • Spinal Cord* / diagnostic imaging

Substances

  • Sildenafil Citrate
  • Phosphodiesterase 5 Inhibitors